Article
Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: a pilot study
2023-04-11
Abstract excerpt
<h4>Background</h4> Individuals with schizophrenia are at elevated genetic risks for comorbid cannabis use, and often experience exacerbations of cognitive and psychotic symptoms when exposed to cannabis. These findings have led a number of investigators to examine cannabinoid CB1 receptor (CB1R) alterations in schizophrenia, though with conflicting results. We recently demonstrated the presence of CB1R in both e...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- dad0b08c-b97b-51d4-9275-64252ab12180
- DOI
- 10.1101/2023.04.11.536217
